Distribution theory of resistance of neurogenic vasoconstriction to alpha-receptor blockade in the rabbit.
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000818:Animals; D001013:Aorta, Thoracic / Q000187:drug effects; D001808:Blood Vessels / Q000378:metabolism; D003042:Cocaine / Q000494:pharmacology; D004558:Electric Stimulation; D066298:In Vitro Techniques; D009119:Muscle Contraction / Q000187:drug effects*; D009489:Neurosecretion / Q000187:drug effects; D009638:Norepinephrine / Q000037:antagonists & inhibitors* / Q000378:metabolism; D010477:Perfusion; D010643:Phenoxybenzamine / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology; D011651:Pulmonary Artery / Q000187:drug effects; D011817:Rabbits; D013564:Sympathetic Nervous System / Q000378:metabolism; D013565:Sympatholytics / Q000494:pharmacology*; D013569:Synapses / Q000502:physiology; D009435:Synaptic Transmission; D014316:Tritium; D014666:Vasomotor System / Q000502:physiology; D015016:Yohimbine / Q000494:pharmacology
D000317:Adrenergic alpha-Antagonists; D013565:Sympatholytics; D010643:Phenoxybenzamine; D014316:Tritium; D015016:Yohimbine; D003042:Cocaine; D009638:Norepinephrine; D010646:Phentolamine